Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma
- PMID: 15941489
- PMCID: PMC1177974
- DOI: 10.1186/1742-6413-2-7
Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma
Abstract
The role of fine needle aspiration biopsy (FNAB) in the evaluation of focal liver lesions has evolved. Guided FNAB is still useful to procure a tissue diagnosis if clinical, biochemical and radiologic findings are inconclusive. Major diagnostic issues include: (i) Distinction of benign hepatocellular nodular lesions from reactive hepatocytes, (ii) Distinction of well-differentiated hepatocellular carcinoma (WD-HCC) from benign hepatocellular nodular lesions, (iii) Distinction of poorly differentiated HCC from cholangiocarcinoma and metastatic carcinomas, (iv) Determination of histogenesis of malignant tumor, and (v) Determination of primary site of origin of malignant tumor. This review gives a general overview of hepatic FNAB; outlines an algorithmic approach to cytodiagnosis with emphasis on HCC, its variants and their mimics; and addresses current diagnostic issues. Close radiologic surveillance of high-risk cirrhotic patients has resulted in the increasing detection of smaller lesions with many subjected to biopsy for tissue characterization. The need for tissue confirmation in clinically obvious HCC is questioned due to risk of malignant seeding. When a biopsy is indicated, core needle biopsy is favored over FNAB. The inherent difficulty of distinguishing small/early HCC from benign hepatocellular nodular lesions has resulted in indeterminate reports. Changing concepts in the understanding of the biological behavior and morphologic evolution of HCC and its precursors; and the current lack of agreement on the morphologic criteria for distinguishing high-grade dysplastic lesions (with small cell change) from WD-HCC, have profound impact on nomenclature, cytohistologic interpretation and management. Optimization of hepatic FNAB to enhance the yield and accuracy of diagnoses requires close clinicopathologic correlation; combined cytohistologic approach; judicious use of ancillary tests; and skilled healthcare teams.
Figures












Similar articles
-
Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis.Cytopathology. 2011 Oct;22(5):287-305. doi: 10.1111/j.1365-2303.2011.00882.x. Epub 2011 Jul 18. Cytopathology. 2011. PMID: 21762411 Review.
-
Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations.Patholog Res Int. 2011;2011:587936. doi: 10.4061/2011/587936. Epub 2011 Jun 30. Patholog Res Int. 2011. PMID: 21789263 Free PMC article.
-
Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.Diagn Cytopathol. 2009 Sep;37(9):629-35. doi: 10.1002/dc.21075. Diagn Cytopathol. 2009. PMID: 19405109
-
Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.Diagn Cytopathol. 2004 Feb;30(2):92-7. doi: 10.1002/dc.10419. Diagn Cytopathol. 2004. PMID: 14755758
-
Differential diagnosis of hepatocellular nodular lesions.Semin Diagn Pathol. 1998 Nov;15(4):285-99. Semin Diagn Pathol. 1998. PMID: 9845429 Review.
Cited by
-
Biopsy or cytology for diagnosing hepatic focal lesions?Clin Mol Hepatol. 2021 Apr;27(2):278-280. doi: 10.3350/cmh.2021.0031. Epub 2021 Mar 4. Clin Mol Hepatol. 2021. PMID: 33657785 Free PMC article. No abstract available.
-
Utility of FNAC in Conjunction with Cell Block for Diagnosing Space-Occupying Lesion (SOL) of Liver with Emphasis on Differentiating Hepatocellular Carcinoma from Metastatic SOL: Analysis of 61 Cases.Oman Med J. 2016 Mar;31(2):135-41. doi: 10.5001/omj.2016.26. Oman Med J. 2016. PMID: 27168925 Free PMC article.
-
Low Dose of Nickel and Benzo [a] Anthracene in Rat-Diet, Induce Apoptosis, Fibrosis, and Initiate Carcinogenesis in Liver via NF-Ƙβ Pathway.Biol Trace Elem Res. 2025 Jan;203(1):305-333. doi: 10.1007/s12011-024-04177-6. Epub 2024 Apr 24. Biol Trace Elem Res. 2025. PMID: 38656682
-
Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma.Cancers (Basel). 2021 Nov 15;13(22):5709. doi: 10.3390/cancers13225709. Cancers (Basel). 2021. PMID: 34830866 Free PMC article.
-
Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma.Diagn Pathol. 2011 Feb 22;6:15. doi: 10.1186/1746-1596-6-15. Diagn Pathol. 2011. PMID: 21338527 Free PMC article.
References
-
- Llatjos M, Muns R, Tallada N. Need for biopsy in hepatocellular carcinoma. J Hepatol. 2001;35:874. (Letter to editor). - PubMed
LinkOut - more resources
Full Text Sources